Inflammation diminishing and sterilizing device

Abstract

The anti-inflammation and sterilization device comprises a spectacle frame, a left lens, a right lens, a power supply module and a control module, the left lens and the right lens are both detachably installed on the glasses frame, an atomization assembly is arranged on the glasses frame and located between the left lens and the right lens, a containing bin is formed in the atomization assembly, a cation exchange membrane arranged in the containing bin divides the containing bin into a first containing bin body and a second containing bin body, and the second containing bin body is close to one side of eyes. At least one first electrode is arranged in the first containing bin, at least one second electrode is arranged in the second containing bin, and the first electrode and the second electrode are both electrically connected with the power module. The atomization assembly is provided with at least one atomization hole, the atomization hole communicates with the second containing bin, the atomization hole is covered with an atomization piece, and the atomization piece is electrically connected with the power module. The control module is configured to be capable of controlling the atomization piece, the first electrode and the second electrode to be turned on or turned off. The eye patch can be applied to ocular or periocular diseases.

Description

Technical Field

[0001] The utility model relates to the field of anti-inflammatory and sterilization, in particular to an anti-inflammatory and sterilization device. Background Art

[0002] The atomization devices currently on the market, especially those that can disinfect and sterilize, generally require the addition of disinfectants for disinfection and sterilization. The use of disinfectants not only increases the cost of use, but also brings safety issues.

[0003] Currently available eye treatment devices are bulky and cumbersome to use. They can only be used in specific areas, which can be inconvenient for users. The medications used and their storage are also subject to numerous restrictions, and they are also expensive.

[0004] In view of the above problems, the present invention proposes a solution. Utility Model Content

[0005] In order to solve at least one of the technical problems existing in the current prior art, the utility model provides an anti-inflammatory and sterilization device, which atomizes the solution through reaction, such as micro-mesh atomization, jet atomization, ultrasound, etc., so that the solution adheres to the surface of the eye to achieve the purpose of treating eye diseases, eye care or diseases around the eyes. The solution atomized by the device is conducive to adhesion and absorption, can kill Demodex mites, and relieve inflammation at the same time. The anti-inflammatory and sterilization device of the utility model only needs to add sodium chloride solution such as physiological saline, and can be operated at home by oneself, which is very convenient to use. Its ingenious structural design makes it very simple to operate and can be operated and used by general users. The specific plan is as follows:

[0006] The utility model provides an anti-inflammatory and sterilizing device, comprising an atomizing component, a power module and a control module;

[0007] The atomizer assembly is provided with a storage compartment, in which a cation exchange membrane is provided. The cation exchange membrane separates the storage compartment into a first storage compartment and a second storage compartment. The first storage compartment and the second storage compartment are electrically connected to each other through the cation exchange membrane. At least one first electrode is provided in the first storage compartment, and at least one second electrode is provided in the second storage compartment. Both the first electrode and the second electrode are electrically connected to the power module.

[0008] The atomizing assembly is provided with at least one atomizing hole, the atomizing hole is communicated with the second receiving chamber, the atomizing hole is covered with an atomizing sheet, and the atomizing sheet is electrically connected to the power module;

[0009] The control module is configured to control the activation or deactivation of the atomizing plate, the first electrode, and the second electrode.

[0010] As a preferred embodiment of the anti-inflammatory and sterilizing device of the present invention, it further comprises a frame, a left lens and a right lens;

[0011] The left lens and the right lens can be detachably mounted on the frame. The frame is provided with an atomizing assembly, which is located between the left lens and the right lens.

[0012] As a preferred solution of the anti-inflammatory and sterilization device described in the utility model, the first electrode is a cathode and the second electrode is an anode.

[0013] As a preferred solution of the anti-inflammatory and sterilizing device of the present invention, a liquid level detection PIN is further provided, which can detect whether the first electrode and the second electrode are placed in the solution.

[0014] As a preferred solution of the anti-inflammatory and sterilization device described in the utility model, the first electrode is located above the second electrode, and the liquid level detection PIN and the first electrode are the same electrode.

[0015] As a preferred solution of the anti-inflammatory and sterilization device described in the present invention, the first containing chamber and the second containing chamber are electrically connected to each other only through a cation exchange membrane.

[0016] As a preferred solution of the anti-inflammatory and sterilization device described in the utility model, an opening is provided on the accommodating chamber, the first accommodating chamber and the second accommodating chamber are both connected to the opening, and a sealing cover is closed on the opening.

[0017] As a preferred solution of the anti-inflammatory and sterilization device described in the utility model, a card slot is provided in the receiving chamber, the cation exchange membrane is fixedly arranged on the sealing support member, the sealing support member is sealed and accommodated in the card slot, and the cation exchange membrane in the card slot and the sealing support member separate the receiving chamber into a first receiving chamber and a second receiving chamber.

[0018] As a preferred solution of the anti-inflammatory and sterilization device described in the present invention, the control module includes a control button, and the control button is arranged on the temple of the frame.

[0019] As a preferred solution of the anti-inflammatory and sterilization device described in the utility model, the frame includes a frame and temples foldedly connected to the frame, the temples include a left temple and a right temple, and the angle a between the normal of the atomizing plate and the central axis of the frame is in the range of 67°-69°.

[0020] As a preferred solution of the anti-inflammatory and sterilization device described in the present invention, a accommodating chamber is further provided on the atomizing assembly, the atomizing sheet is accommodated in the accommodating chamber, and the accommodating chamber is communicated with the second accommodating chamber.

[0021] Compared with the existing technology, the technical solution described in this patent has at least one or more of the following beneficial effects:

[0022] This patented solution uses a readily available, inexpensive NaCl solution as the stock solution, reducing consumer care costs. This neutral NaCl solution, devoid of any acidic or alkaline substances, is non-corrosive and chemically hazardous, offering high safety and significantly reducing production, storage, and transportation costs. This stock solution is not only highly versatile and readily available, but also, being free of acidic or alkaline substances, is safe and chemically hazardous, significantly facilitating user operation, production, storage, and transportation.

[0023] This patent uses a reaction to atomize the solution, such as micro-mesh atomization, jet atomization, ultrasound, etc., so that the solution adheres to the ocular surface to achieve the purpose of treating eye diseases, eye care or eye diseases, such as dermatology, wounds, scars or scarring, etc. The solution atomized by the device is conducive to adhesion and absorption, can kill Demodex mites, and relieve inflammation at the same time. In particular, it is conducive to adhesion and absorption on the ocular surface, and can relieve ocular surface inflammation at the same time. Only sodium chloride solution such as physiological saline solution needs to be added to the device of the utility model, and it can be operated by oneself at home, which is very convenient to use. Its ingenious structural design makes it very simple to operate, and ordinary users can operate it by themselves.

[0024] This patent uses special equipment and special methods to convert NaCl solution into a sterilizing and anti-inflammatory solution that can enter the eyes. It is easy to operate and brings great convenience to users. Due to the presence of the cation exchange membrane, the OH generated in the first holding chamber is avoided. - Entering into the second containing chamber ensures the bactericidal and anti-inflammatory effect of HClO in the second containing chamber.

[0025] A gusset plate is provided to facilitate the removal of the atomizer and cleaning of the storage compartment, while also preventing liquid from dripping during use.

[0026] The first electrode in the holding chamber acts as a cathode, and the second electrode acts as an anode. When the power is turned on, a reduction reaction occurs at the cathode in the holding chamber, and the cathode electrolyzes the H2O in the sodium chloride solution in the first holding chamber to produce H2 and OH. - ; Oxidation reaction occurs at the anode, and the anode converts Cl - Electrolysis is Cl2, which dissolves in the solution to produce HCl and HClO. Under the action of the cation exchange membrane, OH at the first electrode - Cannot enter the second storage compartment.

[0027] At least the anode in the containing chamber is a chlorine-evolving electrode. In the sodium chloride solution, an oxidation reaction occurs at the anode to precipitate chlorine gas from the chloride ions in the solution. The chlorine-evolving electrode has strong corrosion resistance, strong chlorine resistance and acid resistance, good stability, good oxidation resistance, and a long working life. It can prevent the anode itself from reacting or producing other products and causing pollution to the electrolyte or cathode products; it can make it easy to discharge bubbles between the electrodes and on the electrode surface, which can effectively reduce the voltage in the electrolytic cell; the shape is easy to make and has a high degree of refinement. Generally, metal electrodes are mainly ruthenium, iridium, and platinum. Other inert electrodes (such as graphite and graphene materials) can also be used as chlorine-evolving electrodes while ensuring the stability of the material shape. The electrode can also be a coated electrode. The electrode substrate is preferably a titanium or titanium alloy substrate, and then the electrode substrate is coated with a metal coating such as ruthenium, iridium, and platinum.

[0028] The hypochlorite ion-containing solution of the utility model can directly enter the eyes and mucous membranes and has good bactericidal and anti-inflammatory effects.

[0029] The utility model can kill bacteria and other microorganisms, and its sterilization principle is as follows:

[0030] 1. Electrolysis produces hypochlorous acid, blocking the bacterial protein synthesis link

[0031] Electrolysis of sodium chloride solution produces hypochlorous acid, an oxidant with strong oxidizing power. Hypochlorous acid works by oxidizing amino acids in enzyme proteins within microorganisms, inactivating them and thereby interfering with their metabolic processes, leading to their death. Hypochlorous acid has a small molecular weight and is uncharged, so it can easily penetrate cell walls and viral coats, reacting with the proteins, nucleic acids, and enzymes within them. The chloride ions produced during the decomposition of hypochlorous acid can alter the osmotic pressure of bacteria and viruses, further inactivating their cells. Furthermore, with long-term use, bacteria will not develop resistance to electrolyzed saline solution, and it has no toxic side effects on the cornea.

[0032] Additional aspects and advantages of the present invention will be given in part in the following description and will become apparent from the following description or learned through practice of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] In order to more clearly illustrate the technical solution of the present invention, the following briefly introduces the drawings required for use in the embodiments or descriptions of the prior art. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative work.

[0034] Figure 1 It is a schematic diagram of the three-dimensional structure of the anti-inflammatory and sterilization device described in this patent;

[0035] Figure 2 This is a schematic diagram of the main structure of the anti-inflammatory and sterilization device described in this patent;

[0036] Figure 3 It is a schematic diagram of the explosion structure of the atomizing assembly described in this patent;

[0037] Figure 4 It is a schematic diagram of the three-dimensional structure of the atomizing assembly described in this patent;

[0038] Figure 5 This is a schematic diagram of a cross-sectional three-dimensional structure of the atomizer assembly described in this patent at one angle;

[0039] Figure 6 This is a schematic diagram of the cross-sectional three-dimensional structure of the atomizer assembly described in this patent from another angle;

[0040] Figure 7 This is a schematic diagram of the circuit structure of the first electrode, second electrode, atomization positive drive and atomization negative drive of the anti-inflammatory and sterilization device described in this patent.

[0041] Among them, 1-frame, 2-left lens, 3-right lens, 10-atomization assembly, 11-accommodation chamber, 12-accommodation chamber, 13-nose pad structure, 101-inner wall, 102-outer wall, 111-cation exchange membrane, 112-first accommodation chamber, 113-second accommodation chamber, 114-first electrode, 115-second electrode, 116-atomization hole, 117-opening, 118-sealing cover, 119-sealing support, 1110-card slot, 121-atomization sheet, 122-first atomization hole, 123-second atomization hole, 124-buckle plate, 125-atomization sheet positive drive, 126-atomization sheet negative drive, 127-seal, 41-control button, 42-circuit board. DETAILED DESCRIPTION

[0042] The following describes in detail embodiments of the present invention, examples of which are shown in the accompanying drawings, wherein the same or similar reference numerals throughout represent the same or similar elements or elements having the same or similar functions. The embodiments described below with reference to the accompanying drawings are exemplary and are intended to be used to explain the present invention, and should not be construed as limiting the present invention. Based on the embodiments of the present invention, all other embodiments obtained by a person of ordinary skill in the art without creative work are within the scope of protection of the present invention.

[0043] In the description of the present invention, it should be understood that the terms "upper", "lower", "top", "bottom", "inside", "outside", "front end", "rear end", "two ends", "one end", "the other end", etc., indicating the orientation or positional relationship, are based on the orientation or positional relationship shown in the accompanying drawings. They are only for the convenience of describing the present invention and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, be constructed and operate in a specific orientation. Therefore, they should not be understood as limiting the present invention. In the description of the present invention, the meaning of "plurality" is two or more, unless otherwise clearly and specifically defined. In addition, the terms "first" and "second" are used for descriptive purposes only and should not be understood as indicating or implying relative importance.

[0044] In the description of this utility model, unless otherwise expressly specified or limited, terms such as "provided with," "equipped with," "connected," "installed," "mounted," "opened," and "fixed" should be understood in a broad sense. For example, they may refer to fixed connections, detachable connections, or integration; mechanical connections or electrical connections; direct connections or indirect connections through an intermediate medium; and internal communication between two components or interaction between two components. Those skilled in the art will understand the specific meanings of the above terms in this utility model based on specific circumstances.

[0045] See also Figure 1-7 ,like Figure 1-7 As shown, the present invention provides an anti-inflammatory and sterilizing device, which includes an atomizing assembly 10, a power module and a control module;

[0046] The atomizer assembly 10 is provided with a storage compartment 11, in which a cation exchange membrane 111 is provided. The cation exchange membrane 111 separates the storage compartment into a first storage compartment 112 and a second storage compartment 113. The first storage compartment 112 and the second storage compartment 113 are electrically connected to each other through the cation exchange membrane 111. At least one first electrode 114 is provided in the first storage compartment 112, and at least one second electrode 115 is provided in the second storage compartment 113. Both the first electrode and the second electrode are electrically connected to the power module.

[0047] The atomizing assembly 10 is provided with at least one atomizing hole 116, which is in communication with the second receiving chamber. The atomizing hole 116 is covered with an atomizing sheet, which is electrically connected to the power module.

[0048] The control module is configured to control the activation or deactivation of the atomizing plate, the first electrode, and the second electrode.

[0049] In a preferred example, it further comprises a frame 1, a left lens 2 and a right lens 3;

[0050] The left lens 2 and the right lens 3 can be detachably mounted on the frame 1 . The frame 1 is provided with an atomizing assembly 10 . The atomizing assembly 10 includes a receiving chamber 11 . The receiving chamber is located between the left lens 2 and the right lens 3 .

[0051] In this example, the second storage chamber 113 is disposed on a side of the storage chamber 11 close to the eyes.

[0052] In this example, the first electrode is a cathode and the second electrode is an anode.

[0053] In this example, the first containing chamber 112 and the second containing chamber 113 are electrically connected to each other only through the cation exchange membrane 111 .

[0054] In this example, a nose support structure 13 is provided on the side of the receiving chamber 11 close to the eyes.

[0055] Preferably, the storage chamber 11 is provided with an opening 117 , the first storage chamber 112 and the second storage chamber 113 are both connected to the opening 117 , and the opening 117 is sealed with a sealing cover 118 . In this example, the opening 117 is provided at the upper portion of the storage chamber 11 .

[0056] Preferably, Figure 1 As shown, the control module includes a control button 41, which can control the operation of the atomizer assembly. Further preferably, the control button 41 is set on the temple of the frame. Even more preferably, the control button 41 is set on the right temple.

[0057] Preferably, Figure 1-2 As shown, the frame includes a frame and temples foldably connected to the frame, and the temples include a left temple and a right temple.

[0058] In a preferred embodiment, a liquid level detection pin is also provided. The pin can detect whether the first electrode and the second electrode are contained within the solution. If the pin detects that the first electrode and / or the second electrode are not in contact with the liquid, the first and second electrodes are deactivated. In this example, the first electrode is located above the second electrode, and the liquid level detection pin and the first electrode are the same electrode. However, this patent is not limited to this embodiment. Alternatively, the second electrode can be located above the first electrode, and so on.

[0059] In a preferred embodiment, Figure 3-6As shown, a storage bin 12 is also provided on the atomization assembly, and an atomizing sheet 121 is accommodated in the storage bin 12. Further preferably, the storage bin 12 is provided on the side wall of the storage bin 11. Specifically, the atomization hole 116 includes a first atomization hole 122 and a second atomization hole 123, and the first atomization hole 122 and the second atomization hole 123 correspond to each other. The atomizing sheet 121 is connected to the second storage bin 113 through the first atomization hole 122, and the atomizing sheet 121 is connected to the outside through the second atomization hole 123. In the example, the storage bin is surrounded by an inner wall 101 and an outer wall 102, and a first atomization hole 122 is provided on the inner wall 101, and a second atomization hole 123 is provided on the outer wall 102.

[0060] In the example, there are two storage chambers 12, and the atomizing hole on one storage chamber sprays the solution to the left eye, and the atomizing hole on the other storage chamber sprays the solution to the right eye. Of course, this patent is not limited to this. Preferably, the two storage chambers are connected. In the example, the atomizing assembly also includes a gusset plate 124, such as Figure 3-5 As shown, the gusset plate 124 is sealed with the outer wall and the bottom on both sides, so that the storage bins on both sides are connected. The gusset plate is provided to facilitate the removal of the atomizer and the cleaning of the storage bin, and also to prevent liquid from dripping during use.

[0061] In the example, Figure 3-5 As shown, the control module also includes at least one circuit board 42, and the first electrode and the second electrode are both connected to the circuit board 42. A positive driver 125 for the atomizer and a negative driver 126 for the atomizer are also provided. Both the positive driver 125 and the negative driver 126 are connected to the circuit board 42, and both are also connected to the atomizer. In this example, a circuit board is also provided inside the right temple, corresponding to the control button.

[0062] In the example, a sealing support member 119 is also included, such as Figure 3 and Figure 5 As shown, a card slot 1110 is provided in the storage chamber, and the cation exchange membrane is fixedly provided on a sealing support 119, which is sealed and accommodated in the card slot. The sealing support serves to allow the solutions in the first storage chamber and the second storage chamber to conduct electricity only through the cation exchange membrane.

[0063] In this example, the atomizing sheet 121 is fixed on the sealing member 127, and the sealing member 127 is provided with a through hole, such as Figure 3 When the atomizing sheet 121 is installed in the storage bin, the through hole is connected to the atomizing hole. The sealing member 127 is mainly used to seal and support the atomizing sheet to prevent the solution in the storage bin from leaking from the atomizing hole.

[0064] In a preferred embodiment, the angle a between the normal of the atomizing sheet and the central axis of the frame is in the range of 67°-69°. Figure 2 As shown, the atomized liquid atomized by the atomizer can basically cover the eye area.

[0065] The utility model also provides an atomization method of an anti-inflammatory and sterilizing device, specifically comprising:

[0066] S1: A certain amount of sodium chloride solution is poured into the containing chamber, and the first electrode and the second electrode in the containing chamber are both placed in the sodium chloride solution;

[0067] S2: Start the anti-inflammatory and sterilization device. The first electrode in the first storage chamber is the cathode, and the second electrode in the second storage chamber is the anode. The cathode electrolyzes H2O in the sodium chloride solution to produce H2 and OH. - The anode converts Cl in the sodium chloride solution into - Electrolysis produces Cl2, which dissolves in the solution to produce HCl and HClO. The cation exchange membrane between the first and second storage compartments blocks the OH in the first storage compartment. - Enter the second storage compartment;

[0068] S3: After the first electrode and the second electrode in the receiving chamber react for a period of time, the control module starts the atomizing plate, which atomizes the HClO solution in the second receiving chamber it is connected to and sprays it into the eye. The solution kills bacteria on the eyeball.

[0069] Preferably, in step S2, the cation exchange membrane can block the OH in the first containing chamber. - Enter the second storage compartment.

[0070] Preferably, in step S2, after the first electrode and the second electrode are powered on, their turn-on voltage is not less than 1.1V, and the subsequent stable voltage range is 1.1-6.5V.

[0071] Preferably, in step S2, the atomizing plate atomizes the HClO solution in the second containing chamber connected thereto and sprays the atomizing plate out of the atomizing assembly to perform anti-inflammatory, sterilization and / or disinfection, etc.

[0072] In step S2, after the first electrode and the third electrode are connected to a power source, the first electrode or the second electrode becomes a cathode, and the third electrode becomes an anode. The following reaction occurs at the cathode and the anode:

[0073] Cathode: 2H2O+2e - =H2↑+2OH -

[0074] Anode: 2Cl - -2e - →Cl2↑

[0075] Cl2+H2O=HCl+HClO

[0076] Preferably, the concentration of the sodium chloride solution is 0.3%-0.9%.

[0077] Preferably, the first electrode and the second electrode are electrode probes. Further preferably, the first electrode and the second electrode are both chlorine evolution electrodes. In a chloride ion solution, an oxidation reaction occurs at the anode to precipitate chlorine gas from the chloride ions in the solution. The chlorine evolution electrode has strong corrosion resistance, strong chlorine resistance and acid resistance, good stability, good oxidation resistance, and a long working life. It can avoid the anode itself from reacting or producing other products and causing pollution to the electrolyte or cathode products; it can make it easy to discharge bubbles between the electrodes and on the electrode surface, which can effectively reduce the voltage in the electrolytic cell; the shape is easy to make and has a high degree of refinement. Generally, metal electrodes are mainly ruthenium, iridium, and platinum. Other inert electrodes (such as graphite, graphene materials) can also be used as chlorine evolution electrodes while ensuring the stability of the material morphology. The electrode substrate preferably uses a titanium alloy substrate or a platinum-plated substrate.

[0078] In the example, Figure 7 As shown, the anti-inflammatory and sterilization device is atomizing glasses. The specific atomizing steps when the atomizing glasses are working include:

[0079] The first step is to generate hypochlorous acid

[0080] A sodium chloride solution with a concentration of 0.3%-0.9% is poured into the holding chamber. The MCU (microcontroller unit) in the control module drives upper arm X (high level) and upper arm Y (low level). The MCU drives lower arm U (low level) and upper arm V (high level). This creates a current loop from power supply Vdd to Q1, RI, Q4, and R1. The second electrode is the anode, and the first electrode is the cathode. Current flows through R1, generating a voltage divider (V1). After filtering through R2 and C1, it enters the MCU AD and samples voltage Vad. The voltage at this port determines whether the current loop is established. If Vad has a voltage, the holding chamber ionization is functioning normally. If not, Vad has a voltage of 0V, indicating abnormal ionization.

[0081] The second step is atomization

[0082] The PWM (pulse width modulation) technology in the control module controls the high-frequency switching of Q21. Current flows through the power supply Vcc through L21, Q21, R23, and GND. The positive and negative drive voltages of the atomizers generate the same frequency, and both atomizers start to operate. The chamber produces nanometer-level mist, which is sprayed toward the eyeball. The hypochlorous acid mist enters the eye and kills bacteria on it.

[0083] Preferably, a liquid level detection PIN is provided in the storage chamber. When the solution level in the storage chamber falls below the liquid level detection PIN, the circuit detects insufficient liquid level and the control module stops the anti-inflammatory and sterilization device from operating, preventing the two atomizer plates from drying out and reducing the life of the atomizer plates. In this example, the liquid level detection PIN and the first electrode are the same electrode. In this example, the PWM frequency is consistent with the fixed frequency of the atomizer plate.

[0084] When the anti-inflammatory and sterilization device is not working: When the storage compartment is not working, the MCU drives the upper arm X (L level) and drives the upper arm Y (L low level); the MCU drives the lower arm U (L low level) and drives the upper arm V (L low level), then the current does not form a loop. The first electrode and the second electrode are in a suspended state and are not charged. The PWM port is low level. Figure 7 The diagram below is a schematic diagram of the circuit structure of the first electrode, the second electrode, the atomization positive drive, and the atomization negative drive. The following table 1 is a driving logic table of the anti-inflammatory and sterilization device circuit:

[0085] Table 1 Driving logic table of the anti-inflammatory and sterilization device circuit

[0086]

[0087] Preferably, after the first electrode and the second electrode are powered on, their turn-on voltage is not less than 1.1 V, the DC stable voltage range of the power supply Vdd is 1.1-6.5 V, and the DC voltage range of the power supply Vcc is 15-30 V. Further preferably, the DC stable voltage range of the power supply Vdd is 1.1-6.5 V.

[0088] The anti-inflammatory and sterilization device provided by this patent is preferably used for eye diseases.

[0089] Preferably, the eye diseases include eye injuries, eye infections, conditions of increased intraocular pressure, conditions of retinal and ocular nerve degeneration, and eye conditions of cataracts. Further preferably, the eye diseases include but are not limited to conditions such as bacterial conjunctivitis, trachoma, viral conjunctivitis, viral keratitis, fungal eye infections, hordeolum, allergic conjunctivitis, corneal ulcers, corneal chemical burns, allergic conjunctivitis, superior limbal keratoconjunctivitis (episcleritis), corneal viral infections, ocular herpes virus infections, corneal scars, scleral pterygium, blepharitis, scleral rupture, corneal angiogenesis, cataract reversal, neovascular macular degeneration, etc.

[0090] Further preferred, of course, also include skin conditions, wounds, scars and scarring around the eyes. Skin conditions include, but are not limited to, acne, rosacea, pustules, cellulitis, skin conditions of fungal infections of the skin, such as tinea pedis, tinea versicolor, tinea versicolor and candidiasis, skin viral infections, such as herpes zoster and shingles, diaper rash, psoriasis, eczema and skin pigmentation disorders, including post-inflammatory hyperpigmentation (PIH), or improving skin hydration. Wounds include, but are not limited to, skin and flesh wounds, such as burns, pressure sores, chronic wounds, diabetic ulcers, elective surgical wounds, bites, especially from dogs or humans, and subsequent wounds and wound infections; scars and scarring include, but are not limited to, treating scar tissue such as keloid scars, or preventing or reducing scar formation; disinfection, sterilization, anti-inflammatory treatment, etc. before intravitreal injections or intracranial, intrascleral, intracorneal, or subconjunctival injections for providing eye treatment.

[0091] All features of the above components can be freely combined without conflict. In addition, changes, modifications and variations in the component structure are also within the scope of protection of this patent.

[0092] In the description of this specification, the reference terms "one embodiment", "another embodiment", "another embodiment", "other embodiments", "example" or "specific example" mean that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic expressions of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described can be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art can combine and combine different embodiments or examples described in this specification.

[0093] Although the embodiments of the present invention have been shown and described above, it can be understood that the above embodiments are illustrative and cannot be understood as limitations of the present invention. Ordinary technicians in this field can change, modify and modify the above embodiments within the scope of the present invention.

Claims

1. An anti-inflammatory and sterilizing device, characterized in that: It includes an atomizing assembly (10), a power module and a control module; The atomizing assembly (10) is provided with a accommodating chamber (11), a cation exchange membrane (111) is provided in the accommodating chamber (11), the cation exchange membrane (111) divides the accommodating chamber into a first accommodating chamber (112) and a second accommodating chamber (113), the first accommodating chamber (112) and the second accommodating chamber (113) are electrically connected to each other through the cation exchange membrane (111), at least one first electrode (114) is provided in the first accommodating chamber (112), and at least one second electrode (115) is provided in the second accommodating chamber (113), and both the first electrode and the second electrode are electrically connected to the power module; At least one atomizing hole (116) is provided on the atomizing assembly (10), the atomizing hole is communicated with the second storage chamber, the atomizing hole (116) is covered with an atomizing sheet, and the atomizing sheet is electrically connected to the power module; The control module is configured to control the activation or deactivation of the atomizing plate, the first electrode, and the second electrode.

2. The anti-inflammatory and sterilizing device according to claim 1, characterized in that: Also includes a frame (1), a left lens (2) and a right lens (3); The left lens (2) and the right lens (3) can be detachably mounted on the frame (1). An atomizing assembly (10) is provided on the frame (1), and the atomizing assembly (10) is located between the left lens (2) and the right lens (3).

3. The anti-inflammatory and sterilizing device according to claim 1, characterized in that: A liquid level detection PIN is also provided, which can detect whether the first electrode and the second electrode are placed in the solution.

4. The anti-inflammatory and sterilizing device according to claim 3, characterized in that: The first electrode is located above the second electrode, and the liquid level detection PIN and the first electrode are the same electrode.

5. The anti-inflammatory and sterilizing device according to claim 1, characterized in that: The first electrode is a cathode and the second electrode is an anode; and / or The first containing chamber (112) and the second containing chamber (113) are electrically connected to each other only through the cation exchange membrane (111).

6. The anti-inflammatory and sterilizing device according to claim 1, characterized in that: An opening (117) is provided on the accommodating bin, the first accommodating bin (112) and the second accommodating bin (113) are both connected to the opening (117), and a sealing cover (118) is sealed on the opening (117).

7. The anti-inflammatory and sterilizing device according to claim 1, characterized in that: A card slot (1110) is provided in the accommodating chamber (11), the cation exchange membrane (111) is fixedly provided on the sealing support (119), the sealing support (119) is sealed and accommodated in the card slot (1110), and the cation exchange membrane (111) and the sealing support (119) in the card slot (1110) separate the accommodating chamber into a first accommodating chamber (112) and a second accommodating chamber (113).

8. The anti-inflammatory and sterilizing device according to claim 1, characterized in that: The control module comprises a control button (41), and the control button (41) is arranged on the temple of the frame.

9. The anti-inflammatory and sterilizing device according to claim 2, characterized in that: The frame includes a frame and temples foldably connected to the frame, the temples include a left temple and a right temple, and an angle a between a normal line of the atomizing sheet and a central axis of the frame is in a range of 67°-69°.

10. The anti-inflammatory and sterilizing device according to claim 1, characterized in that: The atomizing assembly is also provided with a accommodating chamber (12), the atomizing sheet (121) is accommodated in the accommodating chamber (12), and the accommodating chamber (12) is communicated with the second accommodating chamber (113).

Images